Neutralizing antibodies for the prevention and treatment of COVID-19
코로나19 예방 및 치료를 위한 중화항체
Review
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
angiotensin
angiotensin-converting enzyme 2
antibody
binding
binding affinity
cellular receptor
coronavirus disease
Coronavirus disease 2019
Coronavirus-2
COVID-19
effective
Efficiency
focus
followed by
host cell
Immunotherapy
IMPROVE
infection process
information
initiate
membrane fusion
monoclonal antibodies
N-terminal domain
NAb
NAbs
neutralization
Neutralizing activity
neutralizing monoclonal antibodies
neutralizing monoclonal antibody
Protein
provide
provided
RBD
Receptor-binding domain
respiratory
S protein
S1 subunit
S2 subunit
SARS-CoV-2
SARS-CoV-2 protein
SARS-CoV-2 proteins
SARS-CoV-2 S protein
SARS-CoV-2 strains
SARS-CoV-2 variants
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus-2
Spike protein
the receptor-binding domain
the S protein
the S1 subunit
the SARS-CoV-2
therapeutic target
Treatment
treatment of COVID-19
Viral
viral infection
viral spike
virus entry
[DOI] 10.1038/s41423-021-00752-2 PMC 바로가기 [Article Type] Review
[DOI] 10.1038/s41423-021-00752-2 PMC 바로가기 [Article Type] Review